Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 397 to 403 of 403 entries
Sorted by: Best Match Show Resources per page
European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: pharmacological treatment.

European child & adolescent psychiatry

Roessner V, Eichele H, Stern JS, Skov L, Rizzo R, Debes NM, Nagy P, Cavanna AE, Termine C, Ganos C, Münchau A, Szejko N, Cath D, Müller-Vahl KR, Verdellen C, Hartmann A, Rothenberger A, Hoekstra PJ, Plessen KJ.
PMID: 34757514
Eur Child Adolesc Psychiatry. 2021 Nov 10; doi: 10.1007/s00787-021-01899-z. Epub 2021 Nov 10.

In 2011, the European Society for the Study of Tourette Syndrome (ESSTS) published the first European guidelines for Tourette Syndrome (TS). We now present an update of the part on pharmacological treatment, based on a review of new literature...

Cite
Roessner V, Eichele H, Stern JS, et al. European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: pharmacological treatment. Eur Child Adolesc Psychiatry. 2021;doi: 10.1007/s00787-021-01899-z.
Roessner, V., Eichele, H., Stern, J. S., Skov, L., Rizzo, R., Debes, N. M., Nagy, P., Cavanna, A. E., Termine, C., Ganos, C., Münchau, A., Szejko, N., Cath, D., Müller-Vahl, K. R., Verdellen, C., Hartmann, A., Rothenberger, A., Hoekstra, P. J., & Plessen, K. J. (2021). European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: pharmacological treatment. European child & adolescent psychiatry, . https://doi.org/10.1007/s00787-021-01899-z
Roessner, Veit, et al. "European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: pharmacological treatment." European child & adolescent psychiatry vol. (2021). doi: https://doi.org/10.1007/s00787-021-01899-z
Roessner V, Eichele H, Stern JS, Skov L, Rizzo R, Debes NM, Nagy P, Cavanna AE, Termine C, Ganos C, Münchau A, Szejko N, Cath D, Müller-Vahl KR, Verdellen C, Hartmann A, Rothenberger A, Hoekstra PJ, Plessen KJ. European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: pharmacological treatment. Eur Child Adolesc Psychiatry. 2021 Nov 10; doi: 10.1007/s00787-021-01899-z. Epub 2021 Nov 10. PMID: 34757514.
Copy Download .nbib Format: NLM
Approach to Facial Weakness.

Seminars in neurology

Wang Y, Cruz CD, Stern BJ.
PMID: 34826871
Semin Neurol. 2021 Dec;41(6):673-685. doi: 10.1055/s-0041-1726358. Epub 2021 Nov 26.

Facial palsy is a common neurologic concern and is the most common cranial neuropathy. The facial nerve contains motor, parasympathetic, and special sensory functions. The most common form of facial palsy is idiopathic (Bell's palsy). A classic presentation requires...

Cite
Wang Y, Cruz CD, Stern BJ. Approach to Facial Weakness. Semin Neurol. 2021;41(6):673-685doi: 10.1055/s-0041-1726358.
Wang, Y., Cruz, C. D., & Stern, B. J. (2021). Approach to Facial Weakness. Seminars in neurology, 41(6), 673-685. https://doi.org/10.1055/s-0041-1726358
Wang, Yujie, et al. "Approach to Facial Weakness." Seminars in neurology vol. 41,6 (2021): 673-685. doi: https://doi.org/10.1055/s-0041-1726358
Wang Y, Cruz CD, Stern BJ. Approach to Facial Weakness. Semin Neurol. 2021 Dec;41(6):673-685. doi: 10.1055/s-0041-1726358. Epub 2021 Nov 26. PMID: 34826871.
Copy Download .nbib Format: NLM
Native kidney small renal masses in patients with kidney transplants: Does chronic immunosuppression affect tumor biology?.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Bernstein AP, Davuluri M, DeMasi M, Sankin A, Watts K, Aboumohamed A, Stern JM, Rocca J, Greenstein S, Graham JA, Ajaimy M, Liriano-Ward L, Sarungbam J, Kovac E.
PMID: 33750519
Can Urol Assoc J. 2021 Oct;15(10):339-344. doi: 10.5489/cuaj.6996.

INTRODUCTION: We compared clinicopathological characteristics and outcomes of radical nephrectomy (RN) for small renal masses (SRM) in patients with end-stage renal disease (ESRD) before or after transplant at a high-volume urologic and transplant center.METHODS: We performed a retrospective review...

Cite
Bernstein AP, Davuluri M, DeMasi M, et al. Native kidney small renal masses in patients with kidney transplants: Does chronic immunosuppression affect tumor biology?. Can Urol Assoc J. 2021;15(10):339-344doi: 10.5489/cuaj.6996.
Bernstein, A. P., Davuluri, M., DeMasi, M., Sankin, A., Watts, K., Aboumohamed, A., Stern, J. M., Rocca, J., Greenstein, S., Graham, J. A., Ajaimy, M., Liriano-Ward, L., Sarungbam, J., & Kovac, E. (2021). Native kidney small renal masses in patients with kidney transplants: Does chronic immunosuppression affect tumor biology?. Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 15(10), 339-344. https://doi.org/10.5489/cuaj.6996
Bernstein, Ari P, et al. "Native kidney small renal masses in patients with kidney transplants: Does chronic immunosuppression affect tumor biology?." Canadian Urological Association journal = Journal de l'Association des urologues du Canada vol. 15,10 (2021): 339-344. doi: https://doi.org/10.5489/cuaj.6996
Bernstein AP, Davuluri M, DeMasi M, Sankin A, Watts K, Aboumohamed A, Stern JM, Rocca J, Greenstein S, Graham JA, Ajaimy M, Liriano-Ward L, Sarungbam J, Kovac E. Native kidney small renal masses in patients with kidney transplants: Does chronic immunosuppression affect tumor biology?. Can Urol Assoc J. 2021 Oct;15(10):339-344. doi: 10.5489/cuaj.6996. PMID: 33750519; PMCID: PMC8525532.
Copy Download .nbib Format: NLM
Reverse Cheese-Wire Septotomy to Create a Distal Landing Zone for Thoracic Endovascular Aortic Repair.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists

Stern JR, Pham XD, Lee JT.
PMID: 35018867
J Endovasc Ther. 2022 Jan 12;15266028211070966. doi: 10.1177/15266028211070966. Epub 2022 Jan 12.

PURPOSE: The objective of this study is to describe a novel method for creating a distal landing zone for thoracic endovascular aortic repair (TEVAR) in chronic aortic dissection. The technique is described in a patient with prior total arch...

Cite
Stern JR, Pham XD, Lee JT. Reverse Cheese-Wire Septotomy to Create a Distal Landing Zone for Thoracic Endovascular Aortic Repair. J Endovasc Ther. 2022;15266028211070966doi: 10.1177/15266028211070966.
Stern, J. R., Pham, X. D., & Lee, J. T. (2022). Reverse Cheese-Wire Septotomy to Create a Distal Landing Zone for Thoracic Endovascular Aortic Repair. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists, 15266028211070966. https://doi.org/10.1177/15266028211070966
Stern, Jordan R, et al. "Reverse Cheese-Wire Septotomy to Create a Distal Landing Zone for Thoracic Endovascular Aortic Repair." Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists vol. (2022): 15266028211070966. doi: https://doi.org/10.1177/15266028211070966
Stern JR, Pham XD, Lee JT. Reverse Cheese-Wire Septotomy to Create a Distal Landing Zone for Thoracic Endovascular Aortic Repair. J Endovasc Ther. 2022 Jan 12;15266028211070966. doi: 10.1177/15266028211070966. Epub 2022 Jan 12. PMID: 35018867.
Copy Download .nbib Format: NLM
Posttranslational Modifications Mediate the Structural Diversity of Tauopathy Strains.

Cell

Arakhamia T, Lee CE, Carlomagno Y, Kumar M, Duong DM, Wesseling H, Kundinger SR, Wang K, Williams D, DeTure M, Dickson DW, Cook CN, Seyfried NT, Petrucelli L, Steen JA, Fitzpatrick AWP.
PMID: 34890553
Cell. 2021 Dec 09;184(25):6207-6210. doi: 10.1016/j.cell.2021.11.029.

No abstract available.

Cite
Arakhamia T, Lee CE, Carlomagno Y, et al. Posttranslational Modifications Mediate the Structural Diversity of Tauopathy Strains. Cell. 2021;184(25):6207-6210doi: 10.1016/j.cell.2021.11.029.
Arakhamia, T., Lee, C. E., Carlomagno, Y., Kumar, M., Duong, D. M., Wesseling, H., Kundinger, S. R., Wang, K., Williams, D., DeTure, M., Dickson, D. W., Cook, C. N., Seyfried, N. T., Petrucelli, L., Steen, J. A., & Fitzpatrick, A. W. P. (2021). Posttranslational Modifications Mediate the Structural Diversity of Tauopathy Strains. Cell, 184(25), 6207-6210. https://doi.org/10.1016/j.cell.2021.11.029
Arakhamia, Tamta, et al. "Posttranslational Modifications Mediate the Structural Diversity of Tauopathy Strains." Cell vol. 184,25 (2021): 6207-6210. doi: https://doi.org/10.1016/j.cell.2021.11.029
Arakhamia T, Lee CE, Carlomagno Y, Kumar M, Duong DM, Wesseling H, Kundinger SR, Wang K, Williams D, DeTure M, Dickson DW, Cook CN, Seyfried NT, Petrucelli L, Steen JA, Fitzpatrick AWP. Posttranslational Modifications Mediate the Structural Diversity of Tauopathy Strains. Cell. 2021 Dec 09;184(25):6207-6210. doi: 10.1016/j.cell.2021.11.029. PMID: 34890553.
Copy Download .nbib Format: NLM
Predictors of sac regression after fenestrated endovascular aneurysm repair.

Journal of vascular surgery

Li M, Stern JR, Tran K, Deslarzes-Dubuis C, Lee JT.
PMID: 34506890
J Vasc Surg. 2021 Sep 08; doi: 10.1016/j.jvs.2021.08.067. Epub 2021 Sep 08.

OBJECTIVE: Aneurysm sac regression after standard endovascular aortic repair is associated with improved outcomes, but similar data are limited after fenestrated endovascular aortic repair (FEVAR). We sought to evaluate sac regression after FEVAR, and identify any predictors of this...

Cite
Li M, Stern JR, Tran K, et al. Predictors of sac regression after fenestrated endovascular aneurysm repair. J Vasc Surg. 2021;doi: 10.1016/j.jvs.2021.08.067.
Li, M., Stern, J. R., Tran, K., Deslarzes-Dubuis, C., & Lee, J. T. (2021). Predictors of sac regression after fenestrated endovascular aneurysm repair. Journal of vascular surgery, . https://doi.org/10.1016/j.jvs.2021.08.067
Li, Ming, et al. "Predictors of sac regression after fenestrated endovascular aneurysm repair." Journal of vascular surgery vol. (2021). doi: https://doi.org/10.1016/j.jvs.2021.08.067
Li M, Stern JR, Tran K, Deslarzes-Dubuis C, Lee JT. Predictors of sac regression after fenestrated endovascular aneurysm repair. J Vasc Surg. 2021 Sep 08; doi: 10.1016/j.jvs.2021.08.067. Epub 2021 Sep 08. PMID: 34506890.
Copy Download .nbib Format: NLM
Clinical and Financial Implications of 2 Treatment Strategies for Donor-derived Hepatitis C Infections.

Transplantation direct

Stewart ZA, Stern J, Ali NM, Kalia HS, Khalil K, Jonchhe S, Weldon EP, Dieter RA, Lewis TC, Funches N, Crosby S, Seow M, Berger JC, Dagher NN, Gelb BE, Watkins AC, Moazami N, Smith DE, Kon ZN, Chang SH, Reyentovich A, Angel LF, Montgomery RA, Lonze BE.
PMID: 34514117
Transplant Direct. 2021 Sep 07;7(10):e762. doi: 10.1097/TXD.0000000000001222. eCollection 2021 Oct.

Transplanting hepatitis C viremic donor organs into hepatitis C virus (HCV)-negative recipients is becoming increasingly common; however, practices for posttransplant direct-acting antiviral (DAA) treatment vary widely. Protracted insurance authorization processes for DAA therapy often lead to treatment delays.METHODS: At...

Cite
Stewart ZA, Stern J, Ali NM, et al. Clinical and Financial Implications of 2 Treatment Strategies for Donor-derived Hepatitis C Infections. Transplant Direct. 2021;7(10):e762doi: 10.1097/TXD.0000000000001222.
Stewart, Z. A., Stern, J., Ali, N. M., Kalia, H. S., Khalil, K., Jonchhe, S., Weldon, E. P., Dieter, R. A., Lewis, T. C., Funches, N., Crosby, S., Seow, M., Berger, J. C., Dagher, N. N., Gelb, B. E., Watkins, A. C., Moazami, N., Smith, D. E., Kon, Z. N., Chang, S. H., Reyentovich, A., Angel, L. F., Montgomery, R. A., & Lonze, B. E. (2021). Clinical and Financial Implications of 2 Treatment Strategies for Donor-derived Hepatitis C Infections. Transplantation direct, 7(10), e762. https://doi.org/10.1097/TXD.0000000000001222
Stewart, Zoe A, et al. "Clinical and Financial Implications of 2 Treatment Strategies for Donor-derived Hepatitis C Infections." Transplantation direct vol. 7,10 (2021): e762. doi: https://doi.org/10.1097/TXD.0000000000001222
Stewart ZA, Stern J, Ali NM, Kalia HS, Khalil K, Jonchhe S, Weldon EP, Dieter RA, Lewis TC, Funches N, Crosby S, Seow M, Berger JC, Dagher NN, Gelb BE, Watkins AC, Moazami N, Smith DE, Kon ZN, Chang SH, Reyentovich A, Angel LF, Montgomery RA, Lonze BE. Clinical and Financial Implications of 2 Treatment Strategies for Donor-derived Hepatitis C Infections. Transplant Direct. 2021 Sep 07;7(10):e762. doi: 10.1097/TXD.0000000000001222. eCollection 2021 Oct. PMID: 34514117; PMCID: PMC8425828.
Copy Download .nbib Format: NLM
Showing 397 to 403 of 403 entries